Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
Published: February 14th 2022 | Updated: October 31st 2024
Choosing Between Venetoclax or BTK Inhibitors in Frontline CLL
Published: October 29th 2024 | Updated: October 31st 2024
FDA Approves Asciminib in Newly Diagnosed Ph+ CML in Chronic Phase
Published: September 26th 2024 | Updated: October 31st 2024
FDA ODAC Finds Limited Benefit for Checkpoint Inhibitors in Low PD-L1 Gastric Cancer
Published: October 18th 2023 | Updated: October 31st 2024
Tislelizumab With Chemotherapy Improves OS in Advanced Gastric/GEJ Cancer
Published: February 17th 2015 | Updated: October 31st 2024
Novel Trial Program Puts Patients First